Equity
Direct
Sector - Healthcare
NAV as on 06-12-2024
₹ 33.83
1D
Inception Returns
25.2%
/yr
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 July, 2019. The fund is managed by Dhaval Shah. The fund could potentially beat inflation in the long-run.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has given a CAGR return of 25.17% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 39.39%, 20.76% and 26.01% respectively.
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Apollo Hospitals Enterprise Ltd, Aurobindo Pharma Ltd
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.
Minimum investment for lump sum payment is INR 1000.00 and for SIP is INR 100.00. Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth has no lock in period.
Expense ratio | 0.92% |
Benchmark | S&P BSE Healthcare PR |
AUM | ₹882 Cr |
Inception Date | 11 July, 2019 |
Min Lumpsum/SIP | ₹1000/₹100 |
Exit Load | 1.0% |
Lock In | No Lock-in |
TurnOver | 33.35% |
STCG | Selling mutual fund before 1 year, returns taxed at 20%. |
LTCG | After 1 year, 12.5% tax on returns over ₹1.25 lakh/year. |
Risk | Very High Risk |
as on (06-Dec-24)
as on (31-Oct-24)
Top 3 Sectors in October were Health, Financial Services & Basic Materials
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | -1.28% | -1.28% |
6 Month Returns | 18.04% | 18.04% |
1 Year Returns | 39.39% | 39.39% |
3 Years Returns | 76.11% | 20.76% |
5 Years Returns | 217.65% | 26.01% |
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth | -7.22 | -0.75 | 0.27 |
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth | 1.08 | 0.98 | 0.92 |
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth | 1.84 | 0.8 | 1.05 |
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth | 14.47 | 16.07 | 18.49 |